Neuromodulation therapy for phantom limb pain: A review of the current status and future perspectives
Xiaoyan Duan , Lijuan Xie , Peng Tang , Zhou Feng , Han Chen , Rubing Yan , Jingming Hou
Healthcare and Rehabilitation ›› 2026, Vol. 2 ›› Issue (1) : 100068 -100068.
Background: Phantom Limb Pain (PLP) is a common and intractable neuropathic pain condition that occurs following limb amputation, significantly impacting patients’ quality of life. The prevalence of PLP ranges from 45% to 85%. Traditional pharmacological treatments have limited efficacy and are frequently accompanied by significant side effects.
Objective: This review aims to provide a comprehensive overview of the multi-level pathophysiological mechanisms underlying PLP, synthesize clinical evidence on both invasive and non-invasive neuromodulation techniques, analyze differences in therapeutic outcomes and targets, and offer insights for clinical practice and future research.
Methods: This is a narrative review that integrates the existing evidence and current clinical applications of various treatment approaches for PLP.
Results: The mechanisms of PLP involve peripheral nerve ectopic discharges, cortical reorganization, and the interaction of various psychological factors. The short-term efficacy of invasive treatments, such as spinal cord stimulation (SCS) and dorsal root ganglion (DRG) stimulation, ranges from 14% to 80%. DRG stimulation shows more promise in terms of long-term stability. Non-invasive techniques, including repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS), when combined with mirror therapy, can enhance therapeutic outcomes. Emerging technologies, such as brain-computer interfaces (BCI) and temporally interfering stimulation (TIS), remain in the preclinical phase of investigation.
Conclusion: Neuromodulation techniques offer a multi-dimensional treatment strategy for PLP, with potential improvements through parameter standardization, individualized treatment optimization, validation in multi-center randomized controlled trials, and an overall enhancement of clinical efficacy.
Phantom limb pain / Chronic pain / Stimulation / Neuromodulation technology / Invasive stimulation / Non-invasive stimulation
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
|
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
| [90] |
|
| [91] |
|
| [92] |
|
| [93] |
|
| [94] |
|
| [95] |
|
| [96] |
|
| [97] |
|
| [98] |
|
| [99] |
|
| [100] |
|
| [101] |
|
| [102] |
|
| [103] |
|
| [104] |
|
| [105] |
|
| [106] |
|
| [107] |
|
| [108] |
|
| [109] |
|
| [110] |
|
| [111] |
|
/
| 〈 |
|
〉 |